In a Customer Subset, 23andMe Finds No Emotional Distress from Knowledge of BRCA Mutation Status | GenomeWeb

Originally published Feb. 19.

When a cohort of women and men who chose to purchase gene scans from consumer genetics firm 23andMe learned that they were positive for certain BRCA mutations that predispose them and potentially their family members to a heightened risk of breast and ovarian cancer, none described feeling overly anxious and a few even noted feeling "neutral," according to a recent study.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In PLOS this week: transcriptional and translational study of human cytomegalovirus interactions with host cells, spider web DNA study, and more.

The New York Stem Cell Foundation signs a lease for a new space.

Researchers gear up for an international meeting to discuss the ethics of gene editing.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.